0 results available. Select is focused ,type to refine list, press Down to open the menu,
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology,...
The following section summarizes insights on Sandoz Group AG's Upside (Analyst Target):
We've identified the following companies as similar to Sandoz Group AG because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Upside (Analyst Target) in the predictions category include:
The percentage increase (if positive) or decrease (if negative) that professional analysts expect over the current stock price.
Upside (Analyst Target) is the percentage increase (if positive) or decrease (if negative) that professional analysts expect over the current stock price. Downside (Analyst Target) is the inverse of this metric.
Upside = (Analyst Price Target / Stock Price) - 1
The chart above depicts the distribution of upside (analyst target) for companies operating in the Healthcare sector in the Developed economic region. Over 1,530 companies were considered in this analysis, and 1,469 had meaningful values. The average upside (analyst target) of companies in the sector is 311.2% with a standard deviation of 583.2%.
Sandoz Group AG's Upside (Analyst Target) of 13.1% ranks in the 9.3% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,531 |
| Included Constituents | 1,469 |
| Min | -3.1% |
| Max | 5,380.2% |
| Median | 110.8% |
| Mean | 311.2% |
| Standard Deviation | 583.2% |
You can find companies with similar upside (analyst target) using this stock screener.